척수강 내 약물 주입기의 이식 −증례보고−
Implantation of an Intrathecal Drug Administration System −A report of two cases−
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Opioids profoundly inhibit evoked discharges of spinal nociceptive neurons, thereby inhibiting the transmission of pain. Intrathecal administration of opioids using implantable continuous infusion systems is an effective method of pain relief when other treatments have failed, as well as for patients with adequate analgesia on high dose therapy that produces unacceptable side effects. We report two cases of intrathecal pump implantation performed in patients suffering from intractable chronic pain. A test dose of 3 mg morphine was injected into the epidural space. No side effects were noted and patients experienced considerable pain relief. Implantation was performed one day after the test. The initial intrathecal morphine delivery dose was half of the equivalent dose of daily oral intake opioids and the infusion rate was increased gradually under close observation for opioid side effects. Two days post-implantation, both patients were discharged without any complications.
Abstract
Opioids profoundly inhibit evoked discharges of spinal nociceptive neurons, thereby inhibiting the transmission of pain. Intrathecal administration of opioids using implantable continuous infusion systems is an effective method of pain relief when other treatments have failed, as well as for patients with adequate analgesia on high dose therapy that produces unacceptable side effects. We report two cases of intrathecal pump implantation performed in patients suffering from intractable chronic pain. A test dose of 3 mg morphine was injected into the epidural space. No side effects were noted and patients experienced considerable pain relief. Implantation was performed one day after the test. The initial intrathecal morphine delivery dose was half of the equivalent dose of daily oral intake opioids and the infusion rate was increased gradually under close observation for opioid side effects. Two days post-implantation, both patients were discharged without any complications.
참고문헌 (20)
- Yaksh TL, "Analgesia mediated by a direct spinal action of narcotics", Science, 192, pp.1357~1358 (1976)
- Wang JK, "Pain relief by intrathecally applied morphine in man", Anesthesiology, 50, pp.149~151 (1979)
- Raphael JH, "Long-term experience with implanted intrathecal drug administration systems for failed back syndrome and chronic mechanical low back pain", BMC Musculoskelet Disord, 3, pp.17~17 (2002)
- Mercadante S, "Problems of long-term spinal opioid treatment in advanced cancer patients", Pain, 79, pp.1~13 (1999)
- Alper MH, "Intrathecal morphine: a new method of obstetric analgesia?", Anesthesiology, 51, pp.378~379 (1979)
- Onofrio BM, "Continuous low-dose intrathecal morphine administration in the treatment of chronic pain of malignant origin", Mayo Clin Proc, 56, pp.516~520 (1981)
- Paice JA, "Intraspinal morphine for chronic pain: a retrospective, multicenter study", J Pain Symptom Manage, 11, pp.71~80 (1996)
- Winkelmüller M, "Long-term effects of continuous intrathecal opioid treatment in chronic pain of nonmalignant etiology", J Neurosurg, 85, pp.458~467 (1996)
- Thimineur MA, , Pain, 109, pp.242~249 (2004)
- Smith TJ, "Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival", J Clin Oncol, 20, pp.4040~4049 (2002)
- 서귀주, "말기암 환자의 통증치료를 위한 지주막하강내 카테터 거치와 피하 이식형 약제 주입기 삽입-증례보고-", The Korean Journal of Pain, 20(2), pp.29~29 (2007), 대한통증학회
- Hassenbusch SJ, "Cost modeling for alternate routes of administration of opioids for cancer pain", Oncology, 13, pp.63~67 (1999)
- Krames ES, "Intrathecal infusional therapies for intractable pain: patient management guidelines", J Pain Symptom Manage, 8, pp.36~46 (1993)
- Krames ES, "Intraspinal opioid therapy for chronic nonmalignant pain: current practice and clinical guidelines", J Pain Symptom Manage, 11, pp.333~352 (1996)
- Follett KA, "A prospective study of catheter- related complications of intrathecal drug delivery systems", J Pain Symptom Manage, 19, pp.209~215 (2000)
- Flückiger B, "Device-related complications of long-term intrathecal drug therapy via implanted pumps", Spinal Cord, 46, pp.639~643 (2008)
- Hassenbusch S, "Management of intrathecal catheter-tip inflammatory masses: a consensus statement", Pain Med, 3, pp.313~323 (2002)
- Rigler ML, "Cauda equina syndrome after continuous spinal anesthesia", Anesth Analg, 72, pp.275~281 (1991)
- Chrubasik J, "Patient-controlled spinal opiate analgesia in terminal cancer. Has its time really arrived?", Drugs, 43, pp.799~804 (1992)
- Williams JE, "Intrathecal pumps for giving opioids in chronic pain: a systematic review", Health Technol Assess, 4, pp.1~65 (2000)